Healthcare Equipment and Supplies
Company Overview of Aesculap, Inc.
Aesculap, Inc. supplies surgical instruments, implants, and supplies. It offers bipolar forceps, aneurysm clips, cranial fixation, dura substitutes, hydrocephalus shunts, neurosurgical instruments, neuroendoscopy, and spine implants for neurosurgery applications; power systems, such as cardiac and thoracic, maxilofacial plastics, neurosurgery, small bone, and spine products; and surgical instruments, including cardiovascular instruments, electrosurgery, general surgical instruments, laparoscopy, sterile processing products and services for green healthcare, neuro instruments, and retraction systems. The company also provides wound closure products, including surgical sutures, mechanical sutu...
3773 Corporate Parkway
Center Valley, PA 18034
Founded in 1974
Key Executives for Aesculap, Inc.
Vice President of Biologics
Compensation as of Fiscal Year 2014.
Aesculap, Inc. Key Developments
Aesculap, Inc. Announces Caiman® 5 Seal and Cut Technology Line Extension
Aug 29 14
Aesculap, Inc. announced the expansion of its Caiman® 5 Seal and Cut Technology. A tool for open surgery procedures, the Caiman 5mm vessel sealer device will be available in two additional lengths to accommodate a variety of patient sizes for laparoscopic surgery. Caiman's novel hinged-jaw design and extended jaw offers unparalleled benefits for a broad range of procedures in the areas of gynecology, general and urologic surgery. Caiman was developed to address the challenges that come with traditional vessel sealing devices. For a variety of tissue thicknesses, the proprietary hinged jaw provides uniform pressure distribution across the surface of the tissue, resulting in a clean and consistent seal. Caiman Seal and Cut Technology consists of dedicated bipolar electrosurgical instruments intended for use in general surgery and gynecologic surgical procedures where ligation and division of vessels is desired. The instruments create a seal by the application of bipolar electrosurgical RF energy (coagulation) to vascular structure (vessels) interposed between the jaws of the device. A cutting blade is actuated for the division of tissue.
Aesculap, Inc. Launches Lyoplant Onlay Dura Substitute
Jul 3 14
Aesculap, Inc. announced the availability of Lyoplant Onlay, a biological, collagen based, absorbable dura substitution consisting of a bilayer membrane, designed to provide an elevated ease of use. The revolutionary product allows for a simple onlay application with the opportunity to incorporate suture fixation, if necessary. Reliable: Helps protect against CSF leakage, Excellent resorption rates, Superior tensile strength, 10x stronger than Suturable DuraGen and Strong biocompatibility. Simple: Familiar use, Time-saving onlay application, Convenient handling and Superior suture pull-out, 10x stronger than Suturable DuraGen. Versatile: Multi-use: Onlay or Suturable, 40% thinner than Suturable DuraGen, Excellent elasticity and flexibility and helps prevent cortical adhesion. Lyoplant Onlay is indicated as a dura substitute for the repair of the dura mater.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|